Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GeoPharma
Largo, Florida, United Statesgeopharma.co ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
GeoPharma, Inc. developed a diversified portfolio including generic pharmaceuticals for human and veterinary use, nutraceuticals, cosmeceuticals, medical devices, and an early-stage ovarian cancer diagnostic. The US-based business closed in 2015. An unrelated Italian Geopharma focused on osteoarticular nutraceuticals was acquired by DOC Pharma in early 2025.
- Therapeutic areas
- OtherRheumatologyOncologyNeurology
- Modalities
- Small moleculeNutraceuticals
- Industry
- Biotech
02
Partnerships
Trident Biotech
Beyond the preview
Go deeper on GeoPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on GeoPharma.